Drugs / Aggripal®
last change May 2015 re-read 3 minutes ago

Aggripal®

Vaccine

Developed for
influenza
Investigated by
Novartis · Novartis Vaccines

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02427750 Apr → May 2015 influenza Novartis Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Aggripal ClinicalTrials.gov intervention name — accepted as the source's own label NCT02427750 ↗
Modality Vaccine “trivalent, surface antigen, inactivated influenza vaccine” NCT02427750 ↗